WASHINGTON - The flagship U.S. aid program on HIV/AIDS is in jeopardy, a senior Republican warned on Thursday, after U.S. officials said four nurses in Mozambique performed abortions that are banned ...

Terms of the deal were not disclosed in the case, which involved the government’s patents on Gilead’s HIV drugs Truvada and ...

The flagship U.S. aid program on HIV/AIDS is in jeopardy, a senior Republican warned on Thursday, after U.S. officials said four nurses in Mozambique performed abortions that are banned under the ...

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

The director of NIAID is appointed by the head of the NIH, who must be approved by the Senate. Directors have broad ...

The Supreme Court will hear a challenge to Obamacare’s preventive care mandates, giving Trump a chance to reshape rules on ...

The next chapter of the right-wing war on the Affordable Care Act involves a case that targets the preventative care that ...

Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from ...

But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...

Bush "will provide insights into the challenges and triumphs faced during their tenure in office, as well as reflections on ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Sexual agreements and behavioral similarity complicate the association between relationship status and drug use, for at least ...